UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

European heart journal, 2015-09, Vol.36 (33), p.2239-2245

2015

Volltextzugriff (PDF)

The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial

European heart journal, 2012-09, Vol.33 (17), p.2206-2212

2012

Volltextzugriff (PDF)

Multiple clinical profiles of families with the short QT syndrome

Europace (London, England), 2018-06, Vol.20 (FI1), p.f113-f121

2018

Volltextzugriff (PDF)

Electrocardiographic changes in early recognition of Fabry disease

Heart (British Cardiac Society), 2011-03, Vol.97 (6), p.485-490

2011

Volltextzugriff (PDF)

The year in cardiology 2017: arrhythmias and cardiac devices

European heart journal, 2018-02, Vol.39 (6), p.434-441

2018

Volltextzugriff (PDF)

Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents

European heart journal, 2010-01, Vol.31 (2), p.236-242

2010

Volltextzugriff (PDF)

Individualized antithrombotic therapy

Hämostaseologie, 2016, Vol.36 (1), p.26-32

2016

Volltextzugriff (PDF)

Vitamin K antagonists. Ready to be replaced?

Hämostaseologie, 2012, Vol.32 (4), p.249-257

2012

Volltextzugriff (PDF)

Single center experience with a novel short rotating dilator sheath in transvenous lead extraction

Europace (London, England), 2023-05, Vol.25 (Supplement_1)

2023

Volltextzugriff (PDF)

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology

European journal of heart failure, 2020-12, Vol.22 (12), p.2349-2369

2020

Volltextzugriff (PDF)

Systematic screening for right-to-left shunt prior to lead extraction

Europace (London, England), 2022-05, Vol.24 (Supplement_1)

2022

Volltextzugriff (PDF)

Edoxaban for stroke prevention in routine practice patients with atrial fibrillation with and without atherosclerotic disease: a post-hoc sub-study of ETNA-AF-Europe

European heart journal, 2024-10, Vol.45 (Supplement_1)

2024

Volltextzugriff (PDF)

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Europace (London, England), 2017-06, Vol.19 (6), p.891-911

2017

Volltextzugriff (PDF)

Impact of body weight and body mass index on clinical outcomes of edoxaban therapy in atrial fibrillation patients included in the ETNA-AF-Global registry

European heart journal, 2024-10, Vol.45 (Supplement_1)

2024

Volltextzugriff (PDF)

Electrocardiographic predictors of atrial mechanical sensing in patients with leadless VDD pacemakers

Europace (London, England), 2023-05, Vol.25 (Supplement_1)

2023

Volltextzugriff (PDF)

3D atrial strain for prediction of atrial fibrillation recurrence

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Tissue factor in cardiovascular diseases : Molecular mechanisms and clinical implications

Circulation (New York, N.Y.), 2006-02, Vol.113 (5), p.722-731

2006

Volltextzugriff (PDF)

Improved prediction of cardiac, limb and bleeding events in patients with coronary and peripheral arterial disease using machine learning models and artificial intelligence

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Is there a role for half-dose anticoagulation in atrial fibrillation? Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Hypertension and cardiac arrhythmias: a consensus document fromthe European Heart RhythmAssociation (EHRA) and ESC Council on Hypertension, endorsed by the Heart RhythmSociety (HRS), Asia-Pacific Heart RhythmSociety (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)

Europace (London, England), 2017-06, Vol.19 (6), p.891

2017

Volltextzugriff (PDF)

Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis

European heart journal, 2012-11, Vol.33 (22), p.2766-2768

2012

Volltextzugriff (PDF)

Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review

European heart journal, 2015-11, Vol.36 (41), p.2780-2789

2015

Volltextzugriff (PDF)

Left femoral venous access for leadless pacemaker implantation: patient characteristics and outcomes

Europace (London, England), 2021-05, Vol.23 (Supplement_3)

2021

Volltextzugriff (PDF)

ARVC specific autoantibody identifies cardiac sarcoidosis and correlates with inflammation activity

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial

Multiple clinical profiles of families with the short QT syndrome

Electrocardiographic changes in early recognition of Fabry disease

The year in cardiology 2017: arrhythmias and cardiac devices

Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents

Individualized antithrombotic therapy

Vitamin K antagonists. Ready to be replaced?

Single center experience with a novel short rotating dilator sheath in transvenous lead extraction

Systematic screening for right-to-left shunt prior to lead extraction

Edoxaban for stroke prevention in routine practice patients with atrial fibrillation with and without atherosclerotic disease: a post-hoc sub-study of ETNA-AF-Europe

Impact of body weight and body mass index on clinical outcomes of edoxaban therapy in atrial fibrillation patients included in the ETNA-AF-Global registry

Electrocardiographic predictors of atrial mechanical sensing in patients with leadless VDD pacemakers

3D atrial strain for prediction of atrial fibrillation recurrence

Tissue factor in cardiovascular diseases : Molecular mechanisms and clinical implications

Improved prediction of cardiac, limb and bleeding events in patients with coronary and peripheral arterial disease using machine learning models and artificial intelligence

Is there a role for half-dose anticoagulation in atrial fibrillation? Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48

Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis

Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study

Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review

Left femoral venous access for leadless pacemaker implantation: patient characteristics and outcomes

ARVC specific autoantibody identifies cardiac sarcoidosis and correlates with inflammation activity

Suchergebnisse filtern